Comparative efficacy of conformal and conventional radiotherapy in organ conserving treatment of patients with invasive bladder cancer
https://doi.org/10.17650/1726-9776-2008-4-3-45-49
Abstract
Up to now radical cystectomy remains standard treatment modality for invasive transitional cell bladder cancer. Even reconstruction of bladder using other organs can not substitute patient's own organ. Data from numerous prospective single and multi-center trials which enrolled several thousands patients convincingly showed that survival after three-component combined modality treatment consisting of transurethral bladder resection, radiotherapy and chemotherapy is comparable to survival after cystectomy.
About the Authors
S. I. Tkachev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Russian Federation
Moscow
Russian Federation
Moscow
S. V. Medvedev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Russian Federation
Moscow
Russian Federation
Moscow
K. M. Figurin
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Давыдов М.И., Аксель Е.М. Злокачественные новообразования в России и странах СНГ в 2003 г. М.; 2005.
2. Матвеев Б.П., Фигурин К.М., Токтомушев А.Т. Результаты органосохраняющей терапии инвазивного рака мочевого пузыря. Урология 2002;3:3—5.
3. Dalbagni G., Genega E., Hasibe M. et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111—6.
4. Ghoneim M.A. et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases. J Urol 1997;158: 393—9.
5. Lebret T., Herve J.M., Yonneau L. et al. Study of survival after cystectomy for bladder cancer. Report of 504 cases. Prog Urol 2000;10(4):553—60.
6. Stein J.P. et al. Radical cystectomy in invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001;19(3):666—75.
7. Michaelson D., Zietman A. Invasive bladder cancer: The role of bladder preserving therapy. ASCO 2003; p. 457—65.
8. Rodel C., Weiss C., Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. Jpn J Clin Oncol 2006;24(35):5536—44.
9. Matos T., Cufer T., Cervek J. et al. Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach). Int J Radiat Oncol Biol Phys 2000;46(2):403—9.
10. Ярмоненко С.П., Вайнсон А.А. Радиобиология человека и животных. М.; 2004.
11. Саллум С.Ж. Органосохраняющее лечение рака мочевого пузыря T2N0M0. Автореф. дис. … канд. мед. наук. М.; 2005.
12. Shipley W.U., Kaufman D.S., Zehr E. et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002; 60:62—8.
Review
For citations:
Tkachev S.I., Medvedev S.V., Figurin K.M. Comparative efficacy of conformal and conventional radiotherapy in organ conserving treatment of patients with invasive bladder cancer. Cancer Urology. 2008;4(3):45-49. (In Russ.) https://doi.org/10.17650/1726-9776-2008-4-3-45-49
Views:
330
Email this article 